Department of Pathology |
Department of Pathology |
Autopsy Pathology Frozen Section Pathology Molecular pathology Neuropathology Ophthalmic pathology |
Boston: Massachusetts General Hospital |
MD,Universita Degli Studi di Milano Italy MD,University of Milan |
Anatomic Pathology, American Board of Pathology Neuropathology, American Board of Pathology |
Female |
Adult |
Yes |
View list » Aetna Health Inc. AllWays Health (NHP) - ACD AllWays Health (NHP) - PBO Beech Street Blue Cross Blue Shield - Blue Care 65 Blue Cross Blue Shield - Indemnity Blue Cross Blue Shield - Managed Care Blue Cross Blue Shield - Partners Plus BMC HealthNet Mass Health MCO/ACO Cigna (PAL #'s) Commonwealth Care Alliance Fallon Community HealthCare Great-West Healthcare (formally One Health Plan) Harvard Pilgrim Health Plan - ACD Harvard Pilgrim Health Plan - PBO Health Care Value Management (HCVM) Humana/Choice Care PPO Maine Community Health Options (MCHO) MassHealth Medicare Medicare - ACD OSW - Connecticut OSW - Maine OSW - New Hampshire OSW - Rhode Island OSW - Vermont Private Health Care Systems (PHCS) Railroad Medicare Railroad Medicare - ACD Senior Whole Health TriCare Tufts Health Plan Unicare United Healthcare (non-HMO) - ACD United Healthcare (non-HMO) - PBO Well Sense Pediatrics « Hide list |
Anat Stemmer-Rachamimov, MD, is a faculty member of the C. S. Kubik Laboratory for Neuropathology providing diagnostic services, instruction to trainees on the Neuropathology service through didactic teaching sessions and routine sign-out procedures. She is the co-director of the DFHCC Specialized Histopathology Services Core, co-director of the Neuro Oncology Tissue Repository and the director of the Automated Biomarker Laboratory.
Her conference activities include weekly or monthly conferences with Pathology, Neurology and Neuro-Oncology. She has particular interest in tumor pathology and the weekly consensus review sessions in which all primary brain tumors are discussed, along with cases of complexity or particular interest. This session allows the neuropathology staff to maintain a consistent set of diagnostic criteria and terminology.
She is one of four neuropathologists that diagnose approximately 700 in-house surgical neuropathology cases, and 500 consultation cases per year. In a given year, over 900 intra-operative diagnostic consultations are processed.
 
Her research interests focus on identifying the underlying molecular changes in the lesions and malformations associated with hereditary brain tumor syndromes in particular, neurofibromatosis 1, neurofibromatosis 2, schwannomatosis, and tuberous sclerosis
and comparative pathology with genetically modified mouse models.